7 Scleroderma Headlines You Can’t Miss
1 – 8 Scleroderma-Related Conditions You Should Look Out For
Learn more about these eight scleroderma-related conditions you should look out for.
2 – New Cannabinoid-based Drug Slows Fibrosis, Blocks Inflammation in Early Scleroderma Study
A research team has developed a cannabinoid-based drug which stimulates not only one, but two, receptors believed to be involved in fibrosis development in scleroderma. The drug, VCE-004.8, prevented the formation of fibrosis-promoting myofibroblasts in culture and stopped fibrotic changes in a mouse model of dermal fibrosis. Findings from these pre-clinical studies, while early, are promising and may lead to a new therapy for SSc.
3 – Animated Explanation of Scleroderma
In this video, listen to Andras Fazakas from the Nordic Health Organization, explain the basics of systemic sclerosis (scleroderma).
4 – ProMetic Launches Phase 2 Trial in Scleroderma Patients of Fibrosis Drug PBI-4050
Canada-based ProMetic Life Sciences, a global biopharma, recently announced it will launch a double-blind, placebo-controlled Phase 2 clinical trial in patients with scleroderma to evaluate its lead product PBI-4050.
5 – Spotlight on the Ssc patient: Alice Martins Correia; Geneva, Switzerland
“For my blog this week, I would like to introduce Alice to you.
Alice is without doubt, one of the bravest pioneering patients of the global Ssc community, and whose story personalises how devastating and aggressive this diagnosis can be, and, can be, overcome.”
6 – 10 Things to Care for in Scleroderma
Learn more about the things to care for in scleroderma.
7 – Thriving with Scleroderma
In this video by the Scleroderma Foundation, Greater Chicago Chapter, meet Lisa Helfand, writer, public speaker and blogger at ComfortableInMyThickSkin.com.